Catalog No.
PHK35901
Species reactivity
Human
Host species
Rabbit
Isotype
IgG
Clonality
Polyclonal
Immunogen
E. coli - derived recombinant Human PALLD (Ala1000-Gln1093).
Tested applications
ELISA: 1:4000-1:8000, IHC: 1:50-1:100, WB: 1:1000-1:4000
Target
SIH002, Palladin, Sarcoma antigen NY-SAR-77, KIAA0992, PALLD
Purification
Purified by antigen affinity column.
Accession
Q8WX93
Applications
ELISA, IHC, WB
Form
Liquid
Storage buffer
0.01M PBS, pH 7.4, 50% Glycerol, 0.05% Proclin 300.
Stability and Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 2 to 8°C for frequent use. Store at -20 to -80°C for twelve months from the date of receipt.
Single-Cell Transcriptomics Identifies Selective Lineage-Specific Regulation of Genes in Aortic Smooth Muscle Cells in Mice., PMID:39744838
Different Extracellular β-Amyloid (1-42) Aggregates Differentially Impair Neural Cell Adhesion and Neurite Outgrowth through Differential Induction of Scaffold Palladin., PMID:36551236
Splenic clearance of rigid erythrocytes as an inherited mechanism for splenomegaly and natural resistance to malaria., PMID:35843175
Palladin expression is a conserved characteristic of the desmoplastic tumor microenvironment and contributes to altered gene expression., PMID:26333695
Palladin is a marker of liver metastasis in primary pancreatic endocrine carcinomas., PMID:21868544
Elevated expression of stromal palladin predicts poor clinical outcome in renal cell carcinoma., PMID:21738681
Isoform-specific upregulation of palladin in human and murine pancreas tumors., PMID:20436683
Palladin is overexpressed in the non-neoplastic stroma of infiltrating ductal adenocarcinomas of the pancreas, but is only rarely overexpressed in neoplastic cells., PMID:17404500
Isoform-specific regulation of the actin-organizing protein palladin during TGF-beta1-induced myofibroblast differentiation., PMID:16794588
The proline-rich protein palladin is a binding partner for profilin., PMID:16367745
For research use only. Not for human or drug use.
